OTC: SNZZF - Senzime AB (publ)

Yield per half year: -33.22%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Senzime AB (publ)


About Senzime AB (publ)

Senzime AB (publ), a medical device company, develops, manufactures, and markets patient monitoring systems to monitor patients in Europe and the United States.

more details
The company offers TetraGraph, a quantitative neuromuscular transmission monitor; TetraSens for measurement of muscle response to a stimulus; TetraSens Pediatric for decision support; TetraConnect, a data management portal that helps to access, view, and export data records from the TetraGraph in PDF or Excel format; TetraGraph Device Connectivity, which transfers data from the TetraGraph Monitor to patient monitoring systems; and ExSpiron 2Xi, a non-invasive respiratory volume monitor, as well as TetraGraph Philips Interface that enables the transmission of neuromuscular monitoring parameters, TOFC, TOFR, PTC, and TOF bars to Philips patient monitors, as well as TetraGraph readings are displayed on the Philips Intellivue Monitor. It also develops CliniSenz Analyzer for postoperative and continuous patient monitoring in hospital environments; and OnZurf Probe, a sterile single use product based on micro-dialysis technology that enables continuous sampling from gastro-intestinal organs, such as esophagus, stomach, and liver. Senzime AB (publ) has a strategic license and connectivity agreement with Masimo to develop and market the TetraGraph Smart Cable Module that connects directly to Root monitoring system, as well as to their digital hubs to interface with the hospital clinical information system/electronic health records. The company was incorporated in 1999 and is based in Uppsala, Sweden.

Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://senzime.com
Цена ао 0.49
Change price per day: +0.1271% (0.3935)
Change price per week: +0.1271% (0.3935)
Change price per month: -19.59% (0.49)
Change price per 3 month: -25.25% (0.5271)
Change price per half year: -33.22% (0.59)
Change price per year: -36.14% (0.617)
Change price per 3 year: -83.92% (2.45)
Change price per 5 year: -75.84% (1.6305)
Change price per year to date: -21.98% (0.505)

Underestimation

Title Value Grade
P/S 13.23 1
P/BV 2.24 7
P/E 0 0
EV/EBITDA 0 0
Total: 3.5

Efficiency

Title Value Grade
ROA, % -27.67 0
ROE, % -32.92 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % -36.81 0
Yield Ebitda, % 430 10
Yield EPS, % -17.48 0
Total: 2



Head Job title Payment Year of birth
Mr. Philip Siberg Chief Executive Officer 4.6M 1973 (52 years)
Mr. Slavoljub Grujicic Chief Financial Officer N/A 1970 (55 years)
Ms. Johanna Tulkki Chief Operating Officer N/A 1970 (55 years)
Ms. Rianne Lundqvist Waninge Ph.D. Application Scientist N/A
Ms. Paula Treutiger Head of Communication & Investor Relations N/A 1967 (58 years)
Mr. Anders Selin Executive Vice President of Sales N/A 1962 (63 years)
Mr. Anders Jacobson Chief Innovation Officer N/A 1967 (58 years)
Ms. Catrin Molund Executive Vice President of Business Development 163k 1970 (55 years)
Mr. Fredrik Norrby Chief Technology Officer N/A 1976 (49 years)
Mr. Michael Noble Vice President Global Marketing 1988 (37 years)

Address: Sweden, Uppsala, Ulls vAeg 41 - open in Google maps, open in Yandex maps
Website: https://senzime.com